\-\ Texto\\:\\ \ \(0\)\
\-\ drop\\ in\\ the\\ patient\\'s\\ hemoglobin\\ and\\ hematocrit\\ from\\ 9\\.1\\/26\\.7\\ to\\ 5\\.9\\/17\\.4\\ within\\ a\\ 24\\ hour\\ period\\ and\\ the\\ development\\ of\\ a\\ palpable\\ left\\ sided\\ tender\\ adbominal\\ mass\\.\\ \\ just\\ prior\\ to\\ her\\ ct\\ scan\\,\\ while\\ receiving\\ heparin\\,\\ the\\ patient\\'s\\ pt\\ was\\ 18\\.3\\ \\(nml\\ 11\\-13\\.8\\)\\,\\ ptt\\ was\\ 133\\.7\\ \\(23\\.8\\-35\\.5\\)\\,\\ pt\\ ratio\\ 1\\.5\\,\\ inr\\ 2\\.0\\.\ \(0\)\
\-\ temporary\\ withdrawal\\ of\\ anticoagulation\\.\ \(0\)\
\-\ non\\ contrast\\ ct\\ of\\ the\\ abdomen\\ and\\ the\\ pelvis\\ demonstrates\\ a\\ large\\ hyperdense\\ heterogeneous\\ mass\\ at\\ the\\ left\\ lateral\\ abdominal\\ wall\\,\\ not\\ present\\ on\\ a\\ prior\\ ct\\ of\\ the\\ abdomen\\ from\\ less\\ than\\ a\\ week\\ prior\\.\ \(0\)\
\-\ abdominal\\ wall\\ hematoma\\ following\\ the\\ initiation\\ of\\ therapeutic\\ anticoagultion\\.\ \(0\)\
\-\ acute\\ hemorrhage\\/hematoma\ \(0\)\
\-\ abscess\ \(594\)\
\-\ soft\\ tissue\\ neoplasm\ \(2\)\
\-\ 56\\ year\\ old\\ female\\ patient\\ in\\ the\\ intensive\\ care\\ unit\\ found\\ to\\ have\\ a\\ sudden\\ drop\\ in\\ her\\ hemoglobin\\ and\\ hematocrit\\ following\\ the\\ recent\\ initiation\\ of\\ anticoagulation\\ therapy\\ for\\ a\\ pulmonary\\ embolus\\.\ \(1\)\
\-\ this\\ patient\\ was\\ being\\ started\\ on\\ anticoagulation\\ therapy\\ for\\ a\\ recent\\ pulmonary\\ embolism\\ with\\ intravenous\\ heparin\\.\\ \\ her\\ ptt\\ was\\ elevated\\ at\\ 133\\.7\\,\\ which\\ falls\\ beyond\\ the\\ goal\\ of\\ 70\\-90\\ \\(by\\ this\\ institution\\'s\\ laboratory\\)\\ for\\ a\\ patient\\ starting\\ anticoagulation\\.\\ \\ unfortunately\\ patients\\ starting\\ herparin\\ therapy\\ often\\ overshoot\\ their\\ goal\\ ptt\\ values\\ during\\ their\\ initial\\ titration\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ anticoagulation\\:\\ 0\\.2869028178833624\ \(0\)\
\-\ ptt\\:\\ 0\\.2650076418102098\ \(0\)\
\-\ initiation\\:\\ 0\\.20100382565197938\ \(0\)\
\-\ goal\\:\\ 0\\.17568628523779006\ \(0\)\
\-\ starting\\:\\ 0\\.1738167438244289\ \(0\)\
\-\ the\\:\\ 0\\.16963776837593464\ \(0\)\
\-\ heparin\\:\\ 0\\.16887626673413647\ \(0\)\
\-\ drop\\:\\ 0\\.16813382022010812\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.16343857197627398\ \(0\)\
\-\ hematocrit\\:\\ 0\\.15997459407686868\ \(0\)\
\-\ her\\:\\ 0\\.14485414790251566\ \(0\)\
\-\ therapy\\:\\ 0\\.1332196862527649\ \(0\)\
\-\ prior\\:\\ 0\\.12972712757599467\ \(0\)\
\-\ their\\:\\ 0\\.12828716271496957\ \(0\)\
\-\ patient\\:\\ 0\\.12568838148724681\ \(0\)\
\-\ adbominal\\:\\ 0\\.12359920598902986\ \(0\)\
\-\ anticoagultion\\:\\ 0\\.12359920598902986\ \(0\)\
\-\ herparin\\:\\ 0\\.12359920598902986\ \(0\)\
\-\ overshoot\\:\\ 0\\.11810563980643857\ \(0\)\
\-\ titration\\:\\ 0\\.11810563980643857\ \(0\)\
\-\ pt\\:\\ 0\\.11124215685797245\ \(0\)\
\-\ hematoma\\:\\ 0\\.10819045525443394\ \(0\)\
\-\ was\\:\\ 0\\.10774154628132916\ \(0\)\
\-\ of\\:\\ 0\\.10587346718611666\ \(0\)\
\-\ recent\\:\\ 0\\.10466241679896685\ \(0\)\
\-\ withdrawal\\:\\ 0\\.1017932515137321\ \(0\)\
\-\ abdomen\\:\\ 0\\.09431625629841404\ \(0\)\
\-\ pulmonary\\:\\ 0\\.09422033548110752\ \(0\)\
\-\ wall\\:\\ 0\\.0940295065051706\ \(0\)\
\-\ temporary\\:\\ 0\\.09382944678599457\ \(0\)\
\-\ intensive\\:\\ 0\\.09382944678599457\ \(0\)\
\-\ following\\:\\ 0\\.092730057417721\ \(0\)\
\-\ nml\\:\\ 0\\.09174088985523007\ \(0\)\
\-\ ct\\:\\ 0\\.08827199351913351\ \(0\)\
\-\ falls\\:\\ 0\\.08561703322447203\ \(0\)\
\-\ abdominal\\:\\ 0\\.08454094071321042\ \(0\)\
\-\ inr\\:\\ 0\\.08267606937439068\ \(0\)\
\-\ unit\\:\\ 0\\.08267606937439068\ \(0\)\
\-\ embolus\\:\\ 0\\.08267606937439068\ \(0\)\
\-\ beyond\\:\\ 0\\.0805403861307332\ \(0\)\
\-\ receiving\\:\\ 0\\.08026101950553922\ \(0\)\
\-\ unfortunately\\:\\ 0\\.07971899517604146\ \(0\)\
\-\ therapeutic\\:\\ 0\\.0782120211468094\ \(0\)\
\-\ ratio\\:\\ 0\\.0775170584932881\ \(0\)\
\-\ institution\\:\\ 0\\.076432575751752\ \(0\)\
\-\ hour\\:\\ 0\\.07328475595546434\ \(0\)\
\-\ 56\\:\\ 0\\.07217487714033155\ \(0\)\
\-\ values\\:\\ 0\\.07129094627302929\ \(0\)\
\-\ hyperdense\\:\\ 0\\.07114907271180686\ \(0\)\
\-\ intravenous\\:\\ 0\\.07046116856393982\ \(0\)\
\-\ for\\:\\ 0\\.07027555548457336\ \(0\)\
\-\ embolism\\:\\ 0\\.07006458997027072\ \(0\)\
\-\ period\\:\\ 0\\.06757265598206291\ \(0\)\
\-\ sudden\\:\\ 0\\.06683440638661935\ \(0\)\
\-\ started\\:\\ 0\\.06510241743691669\ \(0\)\
\-\ development\\:\\ 0\\.06389344253653799\ \(0\)\
\-\ and\\:\\ 0\\.0638818909720146\ \(0\)\
\-\ just\\:\\ 0\\.06182851037426477\ \(0\)\
\-\ from\\:\\ 0\\.06139047177546984\ \(0\)\
\-\ mass\\:\\ 0\\.059043364965474646\ \(0\)\
\-\ at\\:\\ 0\\.05838477751768519\ \(0\)\
\-\ to\\:\\ 0\\.05796501382959342\ \(0\)\
\-\ in\\:\\ 0\\.057679710151573825\ \(0\)\
\-\ tender\\:\\ 0\\.0565014811594801\ \(0\)\
\-\ laboratory\\:\\ 0\\.056123789767862295\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.05593882032443281\ \(0\)\
\-\ care\\:\\ 0\\.05522320575537567\ \(0\)\
\-\ 24\\:\\ 0\\.05479441043380053\ \(0\)\
\-\ palpable\\:\\ 0\\.05429715090701877\ \(0\)\
\-\ pelvis\\:\\ 0\\.054055201597229666\ \(0\)\
\-\ being\\:\\ 0\\.05385682614569631\ \(0\)\
\-\ this\\:\\ 0\\.053114610975614485\ \(0\)\
\-\ neoplasm\\:\\ 0\\.05276023003607846\ \(0\)\
\-\ left\\:\\ 0\\.05272876212576684\ \(0\)\
\-\ elevated\\:\\ 0\\.052687776380545275\ \(0\)\
\-\ less\\:\\ 0\\.05257981723326843\ \(0\)\
\-\ week\\:\\ 0\\.05198378420233328\ \(0\)\
\-\ initial\\:\\ 0\\.05184727119560092\ \(0\)\
\-\ often\\:\\ 0\\.050429953404702195\ \(0\)\
\-\ found\\:\\ 0\\.05000840113819049\ \(0\)\
\-\ while\\:\\ 0\\.04994923597300616\ \(0\)\
\-\ sided\\:\\ 0\\.0497151255903606\ \(0\)\
\-\ abscess\\:\\ 0\\.04962836669435325\ \(0\)\
\-\ during\\:\\ 0\\.04895359814849426\ \(0\)\
\-\ on\\:\\ 0\\.04668417782054361\ \(0\)\
\-\ scan\\:\\ 0\\.04585369250414035\ \(0\)\
\-\ than\\:\\ 0\\.04381196866977156\ \(0\)\
\-\ patients\\:\\ 0\\.04347832879690361\ \(0\)\
\-\ acute\\:\\ 0\\.04180947031367163\ \(0\)\
\-\ soft\\:\\ 0\\.041146109794664286\ \(0\)\
\-\ tissue\\:\\ 0\\.04054317154413399\ \(0\)\
\-\ present\\:\\ 0\\.03965861993387644\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03882829525704079\ \(0\)\
\-\ large\\:\\ 0\\.03872477000610797\ \(0\)\
\-\ have\\:\\ 0\\.038609241867323715\ \(0\)\
\-\ lateral\\:\\ 0\\.03835598587132648\ \(0\)\
\-\ contrast\\:\\ 0\\.03755231735382079\ \(0\)\
\-\ female\\:\\ 0\\.03729468329164111\ \(0\)\
\-\ non\\:\\ 0\\.03667124912408002\ \(0\)\
\-\ within\\:\\ 0\\.03559614360091715\ \(0\)\
\-\ which\\:\\ 0\\.0351433008121519\ \(0\)\
\-\ by\\:\\ 0\\.032820666801156466\ \(0\)\
\-\ not\\:\\ 0\\.03051118455501182\ \(0\)\
\-\ year\\:\\ 0\\.023818421851061998\ \(0\)\
\-\ old\\:\\ 0\\.022873929928354717\ \(0\)\
\-\ with\\:\\ 0\\.015133818079647445\ \(0\)\
